|
Volumn 9, Issue 2, 2004, Pages 29-30
|
Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
DRUG DERIVATIVE;
GLUCOCORTICOID;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DONOR;
DRUG COMBINATION;
HEART ARREST;
HUMAN;
KIDNEY;
KIDNEY TRANSPLANTATION;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
GLUCOCORTICOIDS;
HEART ARREST;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
PREDNISOLONE;
PROSPECTIVE STUDIES;
TACROLIMUS;
TIME FACTORS;
TISSUE DONORS;
|
EID: 16544376103
PISSN: 14259524
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|